| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |